An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies
暂无分享,去创建一个
E. Compérat | P. Boelle | Y. Chrétien | J. Gligorov | J. Lotz | D. Brault | Alexandre Perrier | G. Lefèvre | M. Boissan | A. Perrier